COGT (Cogent Biosciences, Inc.) Stock Market Reviews

crown

search

Read and share opinions on COGT (Cogent Biosciences, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market

COGT

Cogent Biosciences, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference
Nov 14, 2025
Cogent Biosciences Expects $547 Million in Net Proceeds From Equity, Convertible Notes Offerings
Nov 13, 2025
Cogent Biosciences Prices $475 Million in Combined Equity, Convertible Notes Offerings
Nov 12, 2025
Cogent Biosciences Announces Pricing of Concurrent Public Offerings of Common Stock and 1.625% Convertible Senior Notes Due 2031
Nov 12, 2025
Cogent Biosciences (COGT) Climbs to New Record High on Cancer Treatment Drug Trial
Nov 11, 2025
Cogent Biosciences (COGT): Assessing Valuation After a 119% One-Day Surge and 316% YTD Gain
Nov 11, 2025
Cogent Biosciences Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2031 and Common Stock
Nov 10, 2025
Cogent Biosciences Announces Multiple Presentations at the 67th Annual American Society of Hematology (ASH) Meeting
Nov 3, 2025
Cogent Biosciences (COGT): Assessing Valuation After a 94% Year-to-Date Share Price Surge
Oct 25, 2025
Cogent Biosciences Announces KRAS Poster Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Oct 24, 2025
Cogent Biosciences Announces FDA Breakthrough Therapy Designation for Bezuclastinib
Oct 20, 2025
Cogent Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 29, 2025

Reviews